Reaction
Cerebrospinal Fluid Leakage reporting signals
As of the last recalculation, Cerebrospinal Fluid Leakage appears in 1,821 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is BUPIVACAINE (PRR 37.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bupivacaine | 30 | 37.3 | 37.4 |
| Baclofen | 204 | 30.4 | 30.4 |
| Methylprednisolone Acetate | 10 | 14.3 | 14.4 |
| Octreotide Acetate | 33 | 12.5 | 12.5 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 21 | 10.4 | 10.4 |
| Temozolomide | 18 | 9.9 | 9.9 |
| Pegaspargase | 10 | 9.4 | 9.4 |
| Testosterone | 19 | 9.4 | 9.4 |
| Butalbital, Acetaminophen, And Caffeine | 8 | 8.6 | 8.6 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 6 | 8.0 | 8.0 |
| Triamcinolone Acetonide | 21 | 7.8 | 7.9 |
| Belimumab | 16 | 5.8 | 5.8 |
| Hydromorphone Hydrochloride | 45 | 5.7 | 5.7 |
| Linaclotide | 10 | 4.3 | 4.3 |
| Avapritinib | 4 | 3.8 | 3.8 |
| Eptinezumab-Jjmr | 3 | 3.8 | 3.8 |
| Fremanezumab-Vfrm | 3 | 3.0 | 3.0 |
| Diroximel Fumarate | 3 | 2.9 | 2.9 |
| Droxidopa | 4 | 2.1 | 2.1 |
| Erenumab-Aooe | 10 | 2.1 | 2.1 |
| Galcanezumab-Gnlm | 4 | 1.5 | 1.5 |